Petros Pharmaceuticals, Inc.
PTPI
$0.0204
-$0.0375-64.77%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -75.41% | 62.79% | 67.90% | 57.92% | 59.26% |
| Total Depreciation and Amortization | -13.80% | -13.78% | -25.65% | -33.97% | -40.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 221.18% | -578.96% | -183.82% | -161.34% | -175.91% |
| Change in Net Operating Assets | 624.39% | 839.60% | -71.77% | 646.98% | 120.22% |
| Cash from Operations | 65.87% | 15.98% | -96.09% | 3.11% | 40.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 47.72% | 10.61% | 11.47% | -2.23% | 9.87% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -211.88% | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -160.67% | -159.95% | 823.81% | 1,095.81% | 810.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -346.17% | -307.35% | 101.27% | 129.52% | 127.12% |